X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (354) 354
Publication (75) 75
Patent (19) 19
Book / eBook (7) 7
Book Review (2) 2
Conference Proceeding (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (184) 184
index medicus (130) 130
hematology (124) 124
male (115) 115
female (110) 110
middle aged (109) 109
adult (102) 102
aged (100) 100
oncology (62) 62
treatment outcome (53) 53
adolescent (51) 51
chronic myelogenous leukemia (49) 49
imatinib mesylate (43) 43
aged, 80 and over (39) 39
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (38) 38
benzamides (36) 36
antineoplastic agents - therapeutic use (35) 35
prognosis (35) 35
hemic and lymphatic diseases (34) 34
imatinib (33) 33
fusion proteins, bcr-abl - genetics (32) 32
leukemia, myelogenous, chronic, bcr-abl positive - genetics (32) 32
chronic myeloid leukemia (28) 28
pyrimidines - therapeutic use (28) 28
young adult (28) 28
abridged index medicus (22) 22
bcr-abl (22) 22
care and treatment (22) 22
piperazines - therapeutic use (22) 22
pyrimidines - administration & dosage (22) 22
analysis (21) 21
follow-up studies (21) 21
philadelphia chromosome (21) 21
protein kinase inhibitors - therapeutic use (21) 21
therapy (21) 21
leukemia (20) 20
survival (20) 20
cancer (19) 19
chemistry (19) 19
disease-free survival (19) 19
metallurgy (19) 19
reverse transcriptase polymerase chain reaction (19) 19
disease (18) 18
follow-up (18) 18
remission induction (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
chronic myeloid-leukemia (17) 17
piperazines - administration & dosage (17) 17
survival rate (17) 17
management (16) 16
medicine & public health (16) 16
resistance (16) 16
retrospective studies (16) 16
time factors (16) 16
chemotherapy (15) 15
mutation (15) 15
prospective studies (15) 15
risk factors (15) 15
italy (14) 14
leukemia, myeloid, chronic-phase - drug therapy (14) 14
philadelphia-chromosome (14) 14
protein kinase inhibitors - administration & dosage (14) 14
survival analysis (14) 14
tyrosine kinase inhibitors (14) 14
precursor cell lymphoblastic leukemia-lymphoma - genetics (13) 13
risk (13) 13
acute lymphoblastic-leukemia (12) 12
chronic-phase (12) 12
diagnosis (12) 12
drug therapy (12) 12
expression (12) 12
molecular response (12) 12
multiple myeloma (12) 12
patients (12) 12
pyrimidines - adverse effects (12) 12
antineoplastic agents - adverse effects (11) 11
dasatinib (11) 11
fusion gene transcripts (11) 11
inflammation (11) 11
interferon-alpha (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - pathology (11) 11
medical research (11) 11
medicine (11) 11
mesylate (11) 11
polymerase chain reaction (11) 11
remission (11) 11
stem-cell transplantation (11) 11
stenosis (11) 11
antineoplastic agents - administration & dosage (10) 10
biochemistry (10) 10
cohort studies (10) 10
essential thrombocythemia (10) 10
genetic aspects (10) 10
microbiology (10) 10
tyrosine (10) 10
atherosclerosis (9) 9
beer (9) 9
cell line, tumor (9) 9
chemical surface treatment (9) 9
classification (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (364) 364
Italian (16) 16
German (5) 5
French (3) 3
Portuguese (2) 2
Chinese (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 12/2006, Volume 12, Issue 24, pp. 7374 - 7379
Journal Article
Clinical Management Issues, ISSN 1973-4832, 10/2015, Volume 4, Issue 2S, pp. 3 - 5
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 6041 - 6051
Journal Article
Recenti progressi in medicina, ISSN 0034-1193, 03/2014, Volume 105, Issue 3, p. 100
Myelodysplastic syndromes are now classified according to the 2008 World Health Organization criteria. An accurate risk assessment requires a keen evaluation... 
Myelodysplastic Syndromes - diagnosis | Myelodysplastic Syndromes - therapy | World Health Organization | Age Factors | Risk Assessment | Comorbidity | Humans | Risk Factors | Drug Design | Myelodysplastic Syndromes - classification
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5202 - 5207
Journal Article
International Journal of Hematology, ISSN 0925-5710, 5/2014, Volume 99, Issue 5, pp. 616 - 624
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2005, Volume 23, Issue 18, pp. 4100 - 4109
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2014, Volume 6, Issue 1, p. e2014010
Journal Article
Haematologica, ISSN 0390-6078, 02/2013, Volume 98, Issue 2, pp. 193 - 200
Imatinib has so far been the first-choice treatment in chronic myeloid leukemia with excellent results. However, only a proportion of patients achieve major... 
CHRONIC MYELOGENOUS LEUKEMIA | CHRONIC-PHASE | LOW OCT-1 ACTIVITY | STANDARD-DOSE IMATINIB | TYROSINE KINASE INHIBITOR | MDR1 GENE | FOLLOW-UP | DRUG-RESISTANCE | HEMATOLOGY | MULTIDRUG-RESISTANCE GENE | CML PATIENTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Benzamides - metabolism | Cytochrome P-450 Enzyme System - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Piperazines - metabolism | Antineoplastic Agents - therapeutic use | Pyrimidines - metabolism | Antineoplastic Agents - metabolism | Young Adult | Benzamides - therapeutic use | Cytochrome P-450 CYP3A - genetics | Cation Transport Proteins - metabolism | Adult | Cation Transport Proteins - genetics | Female | Organic Cation Transport Proteins - metabolism | Genotype | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Cytochrome P-450 CYP3A - metabolism | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Alleles | Cytochrome P-450 Enzyme System - genetics | Aged | Polymorphism, Single Nucleotide | Organic Cation Transport Proteins - genetics | Protein Kinase Inhibitors - metabolism
Journal Article
Journal Article